Tracleer Tab. 62.5mg

Ingredient

Bosentan Hydrate

Content

64.541mg (62.5mg as Bosentan)

Indication

1) Treatment of pulmonary artery hypertension (PAH) (WHO Group I) in adults with WHO-FC III or IV symptoms to improve exercise ability
2) Delay the onset of clinical deterioration treatment of PAH (WHO Group 1) in adults with WHO-FC II
3) Reduction of the number of new digital ulcers (DUs) cases in patients with systemic ongoing DU disease caused by systemic sclerosis (SSc)